Idexx Laboratories (IDXX) Financial Forecast Calculator
Interactive 5-year forecast and DCF for Idexx Laboratories. Adjust revenue growth, gross margin, capex intensity, WACC, and terminal growth - see revenue, free cash flow, and enterprise value update in real time. Seeded from Idexx Laboratories’s most recent SEC filings.
Assumptions
Need this as an Excel model?
Keep iterating on the Idexx Laboratories forecast in Excel. The downloadable sample has every assumption you see here plus a fully integrated income statement, balance sheet, cash flow, and debt schedule - five years of SEC historicals and live formulas in a fully editable workbook.
Other Healthcare forecasts
Run the same calculator on a peer.
Frequently asked
What is Idexx Laboratories' core business model?+
Idexx Laboratories operates a classic "razor and razorblade" business model, placing diagnostic instruments in veterinary clinics. This strategy drives highly profitable, recurring revenue from consumable sales and reference laboratory testing.
What are the main revenue drivers for Idexx Laboratories?+
The primary revenue driver for Idexx Laboratories is its Companion Animal Group (CAG), which accounts for approximately 91% of total revenue. This segment benefits from recurring diagnostic consumable sales and reference laboratory testing services.
What is the assumed revenue growth rate in Idexx Laboratories' financial model?+
The financial model for Idexx Laboratories assumes a revenue growth rate of approximately 11.05%. This growth reflects the company's dominant market share in companion animal diagnostics and its innovation-driven approach.
What is Idexx Laboratories' capital expenditure strategy?+
Idexx Laboratories typically allocates 3.5% to 5.0% of its revenue to capital expenditures, with roughly 60% dedicated to growth initiatives. These investments primarily fund the expansion of its global reference laboratory network and manufacturing capacity.
What is the purpose of a financial model for IDEXX Laboratories?+
A financial model for IDEXX Laboratories provides a comprehensive 3-statement forecast and discounted cash flow valuation. Its purpose is to determine the intrinsic equity value and assess if the stock's premium valuation is justified by its recurring diagnostic revenue and margin expansion trajectory.
Is an Excel financial model available for Idexx Laboratories?+
Yes, an Excel financial model for Idexx Laboratories is available for download. This model offers a forecast horizon from FY2026 to FY2030, enabling detailed financial analysis of the company's performance.
Have more financial modelling questions? Contact us
